Mumbai: Drug-maker Sun Pharmaceutical Industries gained over 3% on the bourses on Monday after the company reported 19% growth in net profit to Rs598 crore for the quarter ended 30 September.
Shares of the company jumped by 3.4% to Rs521 on the BSE, while on the NSE, the scrip gained 3.5% to Rs522.
Sun Pharma CMD Dilip Shanghvi. File photo
The drugmaker’s scrip was also the top gainer among the Sensex-30 blue-chips in morning trade.
Sun Pharmaceutical Industries has reported 19% growth in net profit to Rs598 crore for the quarter ended 30 September on account of robust performance across its businesses.
In the corresponding year-ago period, the company had posted a net profit of Rs503.65 crore.
On a standalone basis, Sun Pharma’s net profit increased to Rs437.55 crore in the second quarter ended 30 September from Rs345.72 crore in the year-ago period.